A mutant cell with a novel defect in MHC class I quality control

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 6839-6846

  York, Ian A ^a   Grant, Ethan P ^b,c   Dahl, A Maria ^b,d   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

^d IPSEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CALNEXIN; CALRETICULIN; GLUCOSE REGULATED PROTEIN 78; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN DISULFIDE ISOMERASE; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ALLELE; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL MUTANT; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SITE DIRECTED MUTAGENESIS;

EID: 18944388139     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.6839     Document Type: Article

References (56)

1. York, I. A., A. L. Goldberg, X. Y. Mo, and K. L. Rock. 1999. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172: 49-66.
2. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20: 463-493.
3. Solheim, J. C. 1999. Class I MHC molecules: assembly and antigen presentation. Immunol. Rev. 172: 11-19.
4. Paulsson, K., and P. Wang. 2003. Chaperones and folding of MHC class I molecules in the endoplasmic reticulum. Biochim. Biophys. Acta 1641: 1-12.
5. Kahn-Perles, B., J. Salamero, and O. Jouans. 1994. Biogenesis of MHC class I antigens: involvement of multiple chaperone molecules. Eur. J. Cell Biol. 64: 176-185.
6. Nossner, E, and P. Parham. 1995. Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J. Exp. Med. 181: 327-337.
7. 2-microglobulin and peptide. J. Exp. Med. 175: 1653-1661.
8. Hughes, E. A., and P. Cresswell. 1998. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr. Biol. 8: 709-712.
9. Lindquist, J. A., O. N. Jensen, M. Mann, and G. J. Hammerling. 1998. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J. 17: 2186-2195.
10. Morrice, N. A., and S. J. Powis. 1998. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr. Biol. 8: 713-716.
11. Gao, B., R. Adhikari, M. Howarth, K. Nakamura, M. C. Gold, A. B. Hill, R. Knee, M. Michalak, and T. Elliott. 2002. Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 16: 99-109.
12. Harris, M. R., L. Lybarger, Y. Y. Yu, N. B. Myers, and T. H. Hansen. 2001. Association of ERp57 with mouse MHC class I molecules is tapasin dependent and mimics that of calreticulin and not calnexin. J. Immunol. 166: 6686-6692.
13. Ortmann, B., J. Copeman, P. J. Lehner, B. Sadasivan, J. A. Herberg, A. G. Grandea, S. R. Riddell, R. Tamṕ, T. Spies, J. Trowsdale, and P. Cresswell. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277: 1306-1309.
14. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5: 103-114.
15. 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158: 2236-2241.
16. Schoenhals, G. J., R. M. Krishna, A. G. Grandea, 3rd, T. Spies, P. A. Peterson, Y. Yang, and K. Fruh. 1999. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells. EMBO J. 18: 743-753.
17. Lehner, P. J., M. J. Surman, and P. Cresswell. 1998. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line, 220. Immunity 8: 221-231.
18. Grandea, A. G., 3rd, T. N. Golovina, S. E. Hamilton, V. Sriram, T. Spies, R. R. Brutkiewicz, J. T. Harty, L. C. Eisenlohr, and L. Van Kaer. 2000. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13: 213-222.
19. Vassilakos, A., M. F. Cohen-Doyle, P. A. Peterson, M. R. Jackson, and D. B. Williams. 1996. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15: 1495-1506.
20. Parham, P., C. J. Barnstable, and W. F. Bodmer. 1979. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immunol. 123: 342-349.
21. Brodsky, F. M., P. Parham, C. J. Barnstable, M. J. Crumpton, and W. F. Bodmer. 1979. Monoclonal antibodies for analysis of the HLA system. Immunol. Rev. 47: 3-61.
22. Parham, P., and W. F. Bodmer. 1978. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 276: 397-399.
23. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
24. Scheinberg, D. A., M. K. Bull, S. Y. Yang, K. A. Class, and J. G. Minniti. 1991. Inhibition of cell proliferation with an HLA-A-specific monoclonal antibody. Tissue Antigens 38: 213-223.
25. Yang, S. Y., Y. Morishima, N. H. Collins, T. Alton, M. S. Pollack, E. J. Yunis, and B. Dupont. 1984. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics 19: 217-231.
26. Berger, A. E., J. E. Davis, and P. Cresswell. 1982. Monoclonal antibody to HLA-A3. Hybridoma 1: 87-90.
27. d antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125: 2473-2477.
28. Tada, N., S. Kimura, A. Hatzfeld, and U. Hammerling. 1980. Ly-m11: the H-3 region of mouse chromosome 2 controls a new surface alloantigen. Immunogenetics 11: 441-449.
29. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
30. Caton, A. J., G. G. Brownlee, J. W. Yewdelt, and W. Gerhard. 1982. The antigénic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31: 417-427.
31. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184.
32. York, I. A., A. X. Mo, K. Lemerise, W. Zeng, Y. Shen, C. R. Abraham, T. Saric, A. L. Goldberg, and K. L. Rock. 2003. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18: 429-440.
33. Elliott, J. F., G. R. Albrecht, A. Gilladoga, S. M. Handunnetti, J. Neequaye, G. Lallinger, J. N. Minjas, and R. J. Howard. 1990. Genes for Plasmodium falciparum surface antigens cloned by expression in COS cells. Proc. Natl. Acad. Sci. USA 87: 6363-6367.
34. + T lymphocytes. Cell 77: 525-535.
35. Früh, K., K. Ahn, H. Djaballah, P. Sempé, P. M. van Endert, R. Tampé, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
36. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
37. 2-microglobulin blocks the extracellular folding of a major histocompatibility complex class I heavy chain. J. Biol. Chem. 278: 5630-5638.
38. Wong, D. K., D. D. Dudley, N. H. Afdhal, J. Dienstag, C. M. Rice, L. Wang, M. Houghton, B. D. Walker, and M. J. Koziel. 1998. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160: 1479-1488.
39. 2m. Eur. J. Immunol. 25: 1609-1616.
40. 2-microglobulin: interactions with murine MHC I molecules. Mol. Immunol. 35: 919-928.
41. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771.
42. Brossart, P., and M. J. Bevan. 1997. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90: 1594-1599.
43. Wick, M. J., and J. D. Pfeifer. 1996. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur. J. Immunol. 26: 2790-2799.
44. Craiu, A., M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272: 13437-13445.
45. Garbi, N., P. Tan, A. D. Diehl, B. J. Chambers, H. G. Ljunggren, F. Momburg, and G. J. Hammerling. 2000. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat. Immunol. 1: 234-238.
46. Barnden, M. J., A. W. Purcell, J. J. Gorman, and J. McCluskey. 2000. Tapasin-mediated retention and optimization of peptide ligands during the assembly of class I molecules. J. Immunol. 165: 322-330.
47. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
48. Jones, T. R., and L. Sun. 1997. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71: 2970-2979.
49. Oliver, J. D., F. J. van der Wal, N. J. Bulleid, and S. High. 1997. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 275: 86-88.
50. Tatu, U., and A. Helenius. 1997. Interactions between newly synthesized glycoproteins, calnexin, and a network of resident chaperones in the endoplasmic reticulum. J. Cell Biol. 136: 555-565.
51. Ellgaard, L., and A. Helenius. 2003. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4: 181-191.
52. Molinari, M., K. K. Eriksson, V. Calanca, C. Galli, P. Cresswell, M. Michalak, and A. Helenius. 2004. Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol. Cell 13: 125-135.
53. Scott, J. E., and J. R. Dawson. 1995. MHC class I expression and transport in a calnexin-deficient cell line. J. Immunol. 155: 143-148.
54. Dick, T. P., N. Bangia, D. R. Peaper, and P. Cresswell. 2002. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity 16: 87-98.
55. Farmery, M. R., S. Allen, A. J. Allen, and N. J. Bulleid. 2000. The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeabilized cell translation system. J. Biol. Chem. 275: 14933-14938.
56. Tector, M., and R. D. Salter. 1995. Calnexin influences folding of human class I histocompatibility proteins but not their assembly with β2-microglobulin. J. Biol. Chem. 270: 19638-19642.